Solasia Pharma KK
TSE:4597
Solasia Pharma KK
Revenue
Solasia Pharma KK
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Solasia Pharma KK
TSE:4597
|
Revenue
¥617m
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Revenue
¥26B
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
64%
|
|
PeptiDream Inc
TSE:4587
|
Revenue
¥28.7B
|
CAGR 3-Years
35%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Revenue
¥47.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Revenue
¥2.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
S
|
StemRIM Inc
TSE:4599
|
Revenue
¥2.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
See Also
What is Solasia Pharma KK's Revenue?
Revenue
617m
JPY
Based on the financial report for Dec 31, 2023, Solasia Pharma KK's Revenue amounts to 617m JPY.
What is Solasia Pharma KK's Revenue growth rate?
Revenue CAGR 5Y
14%
Over the last year, the Revenue growth was -43%. The average annual Revenue growth rates for Solasia Pharma KK have been 11% over the past three years , 14% over the past five years .